Creatine after 50: compare records before promises

CoreAge’s current Strong Suit page identifies unflavored creatine monohydrate. Its online panel lists a 5.6-gram scoop containing 5 grams of the named ingredient and thirty servings, with no other ingredients stated. The mass difference is left unexplained rather than reconciled through an invented formula. Product page Panel and offer

The main options are $228 for twelve months, $149.94 for six, $87 for three and $39 for one, with respective serving counts of 360, 180, ninety and thirty. The CoreAge review places those totals beside the monthly displays and optional refill terms. A lowest monthly equivalent is not the smallest initial commitment.

The checked Thorne page is Creatine — 90 Servings, SKU SF903, with a $44 display. Its ingredient information lists 5 grams of creatine monohydrate per labeled scoop and ninety servings. The page also links a larger version, but the stated price should remain attached to the ninety-serving record. Thorne product page

An NSF issuer entry identifies unflavored Thorne powder in 450- and 900-gram packages and names covered lots. The linked label shows ninety servings for the pictured version. That helps match a product record; it does not verify a container held by a reader. Our Thorne review keeps the matching details and that limitation together. NSF Thorne entry

Momentous’s current ninety-serving unflavored page identifies Signature Spec creatine and explicitly says it no longer sources Creapure. Its current online panel names Momentous creatine monohydrate. An NSF directory entry for the unflavored 450-gram product exists, but the linked label image still names Creapure. Current Momentous page NSF entry

The Momentous review treats this as an unresolved version correspondence. It does not declare the new product uncertified or pretend the older image verifies a supplied new-version lot. Brand name, package size and ingredient-source wording are separate pieces of a match, particularly when a manufacturer publicly announces a change.

NSF describes checks for label agreement, prohibited substances, unsafe contaminant levels and manufacturing controls. Those are meaningful quality-related dimensions. They do not constitute a randomized trial of strength, walking ability or independence in adults over 50. The certification guide considers what the mark answers and what it leaves to other evidence. NSF scope

Similarly, FDA explains that dietary supplements are not approved by the agency for safety and effectiveness before marketing. An FDA-registered facility claim, a manufacturer testing statement and an independent certification are distinct. No one of them supplies a blanket finding about an individual’s health, medicine list or likely benefit. FDA consumer information

Momentous currently displays $42.99 as the regular price and $32.24 for a selected subscription promotion, with ten percent off future deliveries and a $99 free-shipping threshold. Those qualifications differ from CoreAge’s one-time bundle description. They should not be collapsed into a uniform monthly cost for all three brands. Momentous offer CoreAge terms

The container-record guide separates a serving count from a personal schedule. The comparison therefore provides no cost-per-prescribed-day calculation or annual plan recommendation. Taxes, destination charges, promotion eligibility and the final contents of an order were not verified through checkout. A displayed savings percentage is a commercial statement, not an outcome measure.

A two-year randomized study involved 237 postmenopausal women, with both groups participating in resistance exercise and walking. Its abstract reported no added effect on the primary femoral-neck bone-density outcome or the reported strength tests, alongside improvement in some other measures. That mixed result illustrates why naming an outcome matters. Primary trial abstract

The training-evidence guide examines the study more closely. It is not a comparison of these three retail products and does not establish the same result in every older adult. NIH’s broader sports-performance summary also notes different individual responses. Neither source justifies choosing a brand on a promise of universally better aging. NIH evidence

A reader may finish with a well-identified package and an unanswered certification-version question, or clear pricing and an unresolved clinical question. Those are useful findings. They are more accurate than filling the gap with a review score, a laboratory-looking badge or a purchase recommendation based on age alone.

The clinician-question guide keeps personal health and medicine issues outside the product ranking. This comparison does not interpret kidney tests, grant safety clearance or suggest a regimen. Its purpose is to make the documentary differences visible so that a professional conversation and a financial decision can use the right information for their separate roles.